Florence Chaverneff, PhD

Editor https://www.rheumatologyadvisor.com

Florence Chaverneff, PhD, is the editor for Clinical Pain Advisor at Haymarket Media. A neuroscientist by training, Florence conducted basic research investigating mechanisms underlying Alzheimer disease, schizophrenia, and multiple sclerosis, and acquired additional experience in stem cell biology.

All articles by Florence Chaverneff, PhD

ACR Convergence 2020

Low LDL Associated With Coronary Atherosclerosis Burden, CVD Risk in Non-Obese Patients With RA

Florence Chaverneff, PhD

November 8, 2020

Burden and progression of coronary atherosclerosis was found to be worsened in non-obese patients with rheumatoid arthritis and low vs high LDL levels.

Osteoarthritis

Tramadol as First-Line Therapy for OA May Be Associated With Greater Mortality

Florence Chaverneff, PhD

March 12, 2019

Treating osteoarthritis in older patients with tramadol vs nonsteroidal anti-inflammatory drugs may be associated with an increased mortality rate during the year following treatment initiation.

ACR 2018 Coverage

Benefits of a Pain and Stress Management Program for the Management of Chronic Pain

Florence Chaverneff, PhD

October 26, 2018

A “Pain and Stress Management” program for the management of chronic pain, was found to be effective in alleviating pain, diminishing stress, promoting self-management of pain, and ameliorating general well-being.

ACR 2018 Coverage

Transcutaneous Electrical Nerve Stimulation Reduces Pain, Fatigue in Fibromyalgia

Florence Chaverneff, PhD

October 26, 2018

Transcutaneous electrical nerve stimulation administered during physical activity may effectively alleviate fibromyalgia-associated pain, fatigue, and disease impact in women.

EULAR 2018 Coverage

Infliximab May Lower Glucocorticoid Requirements, Lead to Remission in Takayasu Arteritis

Florence Chaverneff, PhD

June 15, 2018

Treatment of active Takayasu arteritis with infliximab may result in remission or in a diminished requirement for glucocorticoids.

EULAR 2018 Coverage

Zoledronic Acid May Not Improve Knee Osteoarthritis-Related Pain, Function Long-Term

Florence Chaverneff, PhD

June 15, 2018

Zoledronic acid did not significantly reduce knee pain or bone marrow lesion size overall in patients with knee osteoarthritis over 24 months.

EULAR 2018 Coverage

Tofacitinib May Effectively Alleviate Pain in RA, Psoriatic Arthritis, and Ankylosing Spondylitis

Florence Chaverneff, PhD

June 14, 2018

Tofacitinib may provide a fast and prolonged analgesic effect in patients with rheumatoid arthritis or psoriatic arthritis who are unresponsive to csDMARD or to TNFi, as well as in individuals with ankylosing spondylitis.

Practice Management

April 28 Is Drug Take Back Day

Florence Chaverneff, PhD

April 27, 2018

April 28, 2018 is National Prescription Drug Take Back Day.

Have Any New Predictive Biomarkers Been Identified?

Vasculitis

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Biomarkers Identified

Florence Chaverneff, PhD

October 17, 2017

Several circulating biomarkers for antineutrophil cytoplasmic antibody-associated vasculitis disease activity and organ involvement were identified using targeted serum proteomics.